<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635347</url>
  </required_header>
  <id_info>
    <org_study_id>Pro20150002276</org_study_id>
    <nct_id>NCT02635347</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study</brief_title>
  <official_title>Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the feasibility of lower limb-ischemia induced Remote Ischemic
      Conditioning (RIC) in the perioperative period before, during, and after Orthotopic Liver
      Transplantation (OLT). Remote ischemic conditioning will consist of 3 cycles of 5 minutes of
      lower limb ischemia induced via a mid-thigh pneumatic tourniquet, followed by 5 minutes of
      reperfusion. Interventions will take place after anesthesia induction but before surgery, at
      the completion of the procedure, and on the mornings of post-operative days 1-4.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Orthotopic liver transplantation (OLT) is associated with a very high risk of complications.
      In a recent multi-center study of 450 patients, 79% had at least one complication and 63% had
      severe (Clavien-Dindo grade III or higher) complications. The number and severity of
      complications are associated with death within 30 days, hospital length of stay, graft and
      patient survival. Infections are the most common group of complications, followed by
      pulmonary, renal and liver graft dysfunction. Interventions that decrease these complications
      after OLT are likely to improve clinical outcomes.

      Remote ischemic conditioning is an innate biological phenomenon wherein a brief single or
      repetitive ischemic stimulus in an organ or tissue such as skeletal muscle induce protection
      in remote/distant organs against ischemia and other noxious stimuli. This effect can be
      induced by inflating a pneumatic tourniquet on a leg or arm for a few minutes (usually 5-10)
      and subsequently deflating to allow reperfusion. This process is usually repeated 3-4 times
      to ensure an adequate dose of the conditioning stimulus. The conditioning stimulus could be
      applied before (Preconditioning), concurrent with (Perconditioning), or soon after the index
      noxious/ischemic insult (Postconditioning).

      The goal of this study is to assess the feasibility, patient acceptance, and safety of RIC in
      liver recipients. In addition, the investigators will obtain data on posttransplant
      complications. Information obtained from this study will help guide the design of a future
      randomized, controlled trial to test the benefit of RIC in liver recipients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients completing entire intervention protocol</measure>
    <time_frame>Pre-op - Post-op day 4</time_frame>
    <description>Proportion of enrolled liver recipients that complete all 6 remote ischemic conditioning (RIC) interventions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intervention-related pain score</measure>
    <time_frame>Post-op days 1-4</time_frame>
    <description>Median intervention-related pain score during each of the post-operative interventions, in extubated patients who are able to communicate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Pre-op - Post-op day 7</time_frame>
    <description>Withdrawal of consent due to discomfort/pain in the lower extremity, or
Any other adverse event thought by the primary clinical team to be related to RIC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early Allograft Dysfunction (EAD)</measure>
    <time_frame>Post-op days 0-7</time_frame>
    <description>Aspartate Transaminase (AST) or Alanine Transaminase (ALT)&gt; 2,000 U/L at any point within the first seven post-transplant days, or
Total Bilirubin (TB) &gt; 10 mg/dL on postoperative day 7,or
International Normalized Ratio (INR)&gt; 1.6 on postoperative day 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolonged Respiratory Insufficiency (PRI)</measure>
    <time_frame>Post-op days 0-7</time_frame>
    <description>Ventilator support for &gt;2 postoperative days after transplant, or
Reintubation after extubation, within 7 days of transplant. Patients who require brief re-intubation for an endoscopic, radiologic, or surgical procedure would not be considered to have PRI if they are extubated within 2 days of the end of the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Kidney Injury (AKI) stages 2 or 3</measure>
    <time_frame>Post-op days 0-7</time_frame>
    <description>Based on Kidney Disease - Improving Global Outcomes (KDIGO) criteria:
Stage 2:
- 2.0-2.9 fold rise in serum creatinine from baseline
Stage 3:
&gt; 3.0 fold rise in serum creatinine from baseline, or
Serum creatinine of &gt; 4.0 mg/dL, with an acute (&lt;48 hours) increase of 0.3 mg/dL in serum creatinine or subacute (&lt; 7 days) increase in serum creatinine of 0.5 mg/dL, or
Initiation of renal replacement therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Dialysis Discontinuation</measure>
    <time_frame>Post-op days 0-90</time_frame>
    <description>In patients who are receiving dialysis pre-op, time to discontinuation of dialysis, if occurring within 90 days of transplantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Clavien-Dindo Grade IIIb or higher complications</measure>
    <time_frame>Post-op days 0-30</time_frame>
    <description>Proportion of patients with Clavien-Dindo &gt;/= grade III b complications (Dindo D, Demartines N, Clavien P, Annals of Surgery 2004).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clavien-Dindo Grade IIIb or higher - number of complications</measure>
    <time_frame>Post-op days 0-30</time_frame>
    <description>In patients with Clavien-Dindo &gt;/= IIIb complications, number of such complications per patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit (ICU) Length of Stay (LOS)</measure>
    <time_frame>Post-op days 0 up to 90 days</time_frame>
    <description>Number of days in ICU post-transplant. Starting at post-op day 0 and ending on the calendar date that the patient is transferred out of ICU, dies, or post-op day 90, whichever is soonest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital LOS</measure>
    <time_frame>Post-op days 0 up to 90 days</time_frame>
    <description>Number of days in hospital post-transplant. Starting at post-op day 0 and ending on the calendar date that the patient is leaves the hospital, dies, or post-op day 90, whichever is soonest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life at 90 days</measure>
    <time_frame>Post-op day 90</time_frame>
    <description>Patient quality of life at 90 days post-transplant as determined by World Health Organization Quality of Life-BREF (WHOQOL-BREF) survey, as well as response rates to surveys administered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Allograft survival</measure>
    <time_frame>Post-op day 90</time_frame>
    <description>Proportion of patients with functioning allograft at 90 days post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient survival</measure>
    <time_frame>Post-op day 90</time_frame>
    <description>Proportion of patients alive at 90 days post-transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of interventions received, if not completing protocol</measure>
    <time_frame>Pre-op - Post-op day 4</time_frame>
    <description>In subjects that receive fewer than 6 interventions, the investigators will report the number</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Liver Failure</condition>
  <condition>Carcinoma, Hepatocellular</condition>
  <arm_group>
    <arm_group_label>Remote Ischemic Conditioning (RIC) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive RIC during transplant and the initial four post-transplant days. During transplant: first intervention after induction of anesthesia but before commencing surgery and the second at the conclusion of the procedure. After transplant: RIC applied daily during the first four consecutive postoperative days. Pneumatic tourniquet will be used to induce RIC</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote Ischemic Conditioning (RIC)</intervention_name>
    <description>Each RIC intervention will comprise three cycles of 5 minutes of inflation followed by 5 minutes of deflation of a pneumatic tourniquet placed in mid-thigh.</description>
    <arm_group_label>Remote Ischemic Conditioning (RIC) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pneumatic tourniquet</intervention_name>
    <description>Portable Tourniquet System(PTSii, Delfi Medical Innovations, Inc.) used to perform RIC interventions.</description>
    <arm_group_label>Remote Ischemic Conditioning (RIC) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (&gt; 18 years of age) with acute and chronic liver failure requiring liver
             transplants or patients undergoing transplantation for hepatocellular carcinoma.

          -  Both sexes

          -  Written consent to participate in the study

        Exclusion Criteria:

          -  &lt; 18 years of age

          -  Recipients of split livers

          -  Retransplantation

          -  Recipients of livers combined with other organs

          -  Recipients of livers from cardiac death donors

          -  Lower extremity amputees

          -  History of peripheral vascular disease

          -  Patients taking sulfonylurea anti-diabetic agents at the time of transplant

          -  Patients taking nitrates at the time of transplant

          -  Body mass index &gt; 45

          -  Pregnant patients

          -  Patients in whom complete lower extremity ischemia is not achieved despite maximum
             tourniquet inflation to 250 mmHg during the first intervention

          -  Patients with lower extremity paralysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baburao Koneru, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers - New Jersey Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rutgers University - University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101-0820</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Parikh A, Washburn KW, Matsuoka L, Pandit U, Kim JE, Almeda J, Mora-Esteves C, Halff G, Genyk Y, Holland B, Wilson DJ, Sher L, Koneru B. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era. Liver Transpl. 2015 Sep;21(9):1160-8. doi: 10.1002/lt.24181.</citation>
    <PMID>25991395</PMID>
  </reference>
  <reference>
    <citation>Huang CT, Lin HC, Chang SC, Lee WC. Pre-operative risk factors predict post-operative respiratory failure after liver transplantation. PLoS One. 2011;6(8):e22689. doi: 10.1371/journal.pone.0022689. Epub 2011 Aug 1.</citation>
    <PMID>21829646</PMID>
  </reference>
  <reference>
    <citation>Levesque E, Hoti E, Azoulay D, Honore I, Guignard B, Vibert E, Ichai P, Antoun F, Saliba F, Samuel D. Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome. Transplantation. 2012 Sep 15;94(5):532-8.</citation>
    <PMID>22885879</PMID>
  </reference>
  <reference>
    <citation>Gracey DR, Divertie MB, Didier EP. Preoperative pulmonary preparation of patients with chronic obstructive pulmonary disease: a prospective study. Chest. 1979 Aug;76(2):123-9.</citation>
    <PMID>456049</PMID>
  </reference>
  <reference>
    <citation>Svensson LG, Hess KR, Coselli JS, Safi HJ, Crawford ES. A prospective study of respiratory failure after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg. 1991 Sep;14(3):271-82.</citation>
    <PMID>1880835</PMID>
  </reference>
  <reference>
    <citation>Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg. 2000 Aug;232(2):242-53.</citation>
    <PMID>10903604</PMID>
  </reference>
  <reference>
    <citation>Hilmi IA, Damian D, Al-Khafaji A, Planinsic R, Boucek C, Sakai T, Chang CC, Kellum JA. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015 Jun;114(6):919-26. doi: 10.1093/bja/aeu556. Epub 2015 Feb 10.</citation>
    <PMID>25673576</PMID>
  </reference>
  <reference>
    <citation>Salvalaggio PR, Felga GE, Afonso RC, Ferraz-Neto BH. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study. Transplant Proc. 2012 Oct;44(8):2449-51. doi: 10.1016/j.transproceed.2012.08.002.</citation>
    <PMID>23026617</PMID>
  </reference>
  <reference>
    <citation>Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, Shaked A, Christie JD. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010 Aug;16(8):943-9. doi: 10.1002/lt.22091.</citation>
    <PMID>20677285</PMID>
  </reference>
  <reference>
    <citation>Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J Surg Res. 2008 Dec;150(2):304-30. doi: 10.1016/j.jss.2007.12.747. Epub 2008 Jan 22. Review.</citation>
    <PMID>19040966</PMID>
  </reference>
  <reference>
    <citation>Przyklenk K, Whittaker P. Genesis of remote conditioning: action at a distance--'hypotheses non fingo'? J Cardiovasc Med (Hagerstown). 2013 Mar;14(3):180-6. doi: 10.2459/JCM.0b013e328358c8eb. Review.</citation>
    <PMID>22964648</PMID>
  </reference>
  <reference>
    <citation>McCafferty K, Forbes S, Thiemermann C, Yaqoob MM. The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech. 2014 Dec;7(12):1321-33. doi: 10.1242/dmm.016741. Review.</citation>
    <PMID>25481012</PMID>
  </reference>
  <reference>
    <citation>Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation. 2007 Sep 11;116(11 Suppl):I98-105.</citation>
    <PMID>17846333</PMID>
  </reference>
  <reference>
    <citation>Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, Haeberle H, Görlich D, Kellum JA, Meersch M; RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015 Jun 2;313(21):2133-41. doi: 10.1001/jama.2015.4189.</citation>
    <PMID>26024502</PMID>
  </reference>
  <reference>
    <citation>Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial. Acta Anaesthesiol Scand. 2012 Jan;56(1):30-8. doi: 10.1111/j.1399-6576.2011.02585.x. Epub 2011 Nov 21.</citation>
    <PMID>22103808</PMID>
  </reference>
  <reference>
    <citation>MacAllister R, Clayton T, Knight R, Robertson S, Nicholas J, Motwani M, Veighey K. REmote preconditioning for Protection Against Ischaemia–Reperfusion in renal transplantation (REPAIR): a multicentre, multinational, double-blind, factorial designed randomised controlled trial. Southampton (UK): NIHR Journals Library; 2015 May.</citation>
    <PMID>26020087</PMID>
  </reference>
  <reference>
    <citation>Gonzalez NR, Hamilton R, Bilgin-Freiert A, Dusick J, Vespa P, Hu X, Asgari S. Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:193-8. doi: 10.1007/978-3-7091-1192-5_36.</citation>
    <PMID>22890668</PMID>
  </reference>
  <reference>
    <citation>Li S, Ma C, Shao G, Esmail F, Hua Y, Jia L, Qin J, Ren C, Luo Y, Ding Y, Borlongan CV, Ji X. Safety and Feasibility of Remote Limb Ischemic Preconditioning in Patients With Unilateral Middle Cerebral Artery Stenosis and Healthy Volunteers. Cell Transplant. 2015;24(9):1901-11. doi: 10.3727/096368914X683520. Epub 2014 Jul 30.</citation>
    <PMID>25198862</PMID>
  </reference>
  <reference>
    <citation>Koch S, Katsnelson M, Dong C, Perez-Pinzon M. Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke. 2011 May;42(5):1387-91. doi: 10.1161/STROKEAHA.110.605840. Epub 2011 Mar 17.</citation>
    <PMID>21415404</PMID>
  </reference>
  <reference>
    <citation>Rehni AK, Shri R, Singh M. Remote ischaemic preconditioning and prevention of cerebral injury. Indian J Exp Biol. 2007 Mar;45(3):247-52.</citation>
    <PMID>17373368</PMID>
  </reference>
  <reference>
    <citation>Section 2: AKI Definition. Kidney Int Suppl (2011). 2012 Mar;2(1):19-36.</citation>
    <PMID>25018918</PMID>
  </reference>
  <reference>
    <citation>Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr;6(4):783-90.</citation>
    <PMID>16539636</PMID>
  </reference>
  <reference>
    <citation>Meng R, Asmaro K, Meng L, Liu Y, Ma C, Xi C, Li G, Ren C, Luo Y, Ling F, Jia J, Hua Y, Wang X, Ding Y, Lo EH, Ji X. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012 Oct 30;79(18):1853-61. doi: 10.1212/WNL.0b013e318271f76a. Epub 2012 Oct 3.</citation>
    <PMID>23035060</PMID>
  </reference>
  <reference>
    <citation>Bilgin-Freiert A, Dusick JR, Stein NR, Etchepare M, Vespa P, Gonzalez NR. Muscle microdialysis to confirm sublethal ischemia in the induction of remote ischemic preconditioning. Transl Stroke Res. 2012 Jun;3(2):266-72. doi: 10.1007/s12975-012-0153-1. Epub 2012 Apr 10.</citation>
    <PMID>24323782</PMID>
  </reference>
  <reference>
    <citation>Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13.</citation>
    <PMID>15273542</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2015</study_first_submitted>
  <study_first_submitted_qc>December 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2015</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Baburao Koneru, MD, MPH</investigator_full_name>
    <investigator_title>Chief, Transplant and Hepatobiliary Surgery</investigator_title>
  </responsible_party>
  <keyword>Remote ischemic preconditioning</keyword>
  <keyword>Remote ischemic perconditioning</keyword>
  <keyword>Remote ischemic postconditioning</keyword>
  <keyword>Remote ischemic conditioning</keyword>
  <keyword>Orthotopic liver transplant</keyword>
  <keyword>Brain Death Organ Donor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Brain Death</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

